Anna L Bruckner MD
Pediatric Dermatology
Pediatric Dermatology at Children's Hospital Colorado
Join to View Full Profile
13123 E 16th Ave# ChildrenAurora, CO 80045
Phone+1 720-777-1234
Dr. Bruckner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Dermatology, 2003 - 2004
University of ColoradoResidency, Dermatology, 2000 - 2003- University of ColoradoResidency, Pediatrics, 1997 - 2000
Northwestern University The Feinberg School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2003 - Present
CO State Medical License 1999 - 2025
American Board of Dermatology Dermatology- American Board of Dermatology Pediatric Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa Start of enrollment: 2020 Jun 09
- A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa Start of enrollment: 2020 Oct 15
Publications & Presentations
PubMed
- Phenotypic Characteristics of a Patient Cohort With Recessive Dystrophic Epidermolysis Bullosa and the Pathogenic Variant c.7485+5G>A in Intron 98 of COL7A1.Micah G Pascual, Hannah C Cox, Austin Larson, Anna L Bruckner
American Journal of Medical Genetics. Part A. 2025-02-27 - Biologics in congenital ichthyosis: are they effective?Juliette Mazereeuw-Hautier, Céline Granier Tournier, Angela Hernandez-Martin, Sarah Milesi, Hélène Texier
The British Journal of Dermatology. 2025-01-24 - Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the Phase III EASE Study.Dédée F Murrell, Christine Bodemer, Anna L Bruckner, Tracy Cunningham, Charles Davis
The British Journal of Dermatology. 2025-01-16
Other
- Clinical and Immunological Study of 30 Cases with Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA DermatosisAnna Bruckner, MD, Frontiers in Neurology
https://www.doximity.com/articles/c6a333ba-3c78-474f-884b-ad5920c94a09
UpToDate, Wolters Kluwer Health - 2012-03-06
Press Mentions
Sniffing Out the Meaning of Perialar IntertrigoJanuary 4th, 2023- IV Gentamicin Improves Junctional Epidermolysis Bullosa in ChildrenApril 1st, 2022
- New Research Offers Details About the Mysterious 'COVID Toes' Symptom — but Raises Questions, TooJune 27th, 2020
- Join now to see all
Grant Support
- Study of the Safety, Tolerability, and Efficacy of an iPS Cell-based Therapy for Recessive Dystrophic Epidermolysis Bullosa Delivered with a Spray on Skin DeviceUNIVERSITY OF COLORADO DENVER2023–2025
- JAK Inhibition in Down SyndromeUNIVERSITY OF COLORADO DENVER2019–2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
